Literature DB >> 16626422

Conjunctival impression cytology in pseudoexfoliative glaucoma and pseudoexfoliation syndrome.

Haydar Erdoğan1, D Sema Arici, M Ilker Toker, M Kemal Arici, Gönül Fariz, Ayşen Topalkara.   

Abstract

BACKGROUND: In this study, ocular surface changes and tear film functions in patients with pseudoexfoliative glaucoma (PEXG) and pseudoexfoliation (PEX) syndrome were evaluated.
METHODS: This study is a randomized, double-blind and prospective study. Conjunctival impression cytology, tear film break-up time (TFBUT) test and basal Schirmer test (BST) were performed on 45 eyes of 45 subjects with PEXG (group I), 48 eyes of 48 subjects with PEX syndrome (group 2) and 50 eyes of 50 normal subjects (group 3). Impression cytology was graded 0-III based on the shape, eosinophilic-staining cytoplasm and nucleocytoplasmic ratio of the epithelial cells, and the shape, quantity and Periodic Acid Schiff-positive cytoplasm of the goblet cells.
RESULTS: Impression cytology grading scores were 6.7% grade 0, 15.6% grade I, 37.7% grade II and 40% grade III in group 1, 6.3%, 18.7%, 43.8% and 31.2% in group 2 and 38%, 36.0%, 20% and 6% in group 3, respectively. The scores in groups 1 and 2 were significantly higher than in group 3 (P = 0.001, chi(2) = 39.84). The mean values of TFBUT of groups 1, 2 and 3 were 5.91 +/- 3.27, 7.39 +/- 4.82, 10.96 +/- 3.81 s and the mean values of BST were 7.82 +/- 3.56, 9.04 +/- 4.60 and 12.50 +/- 5.25 mm/5 min, respectively. The values of TFBUT and BST were lower in groups 1 and 2 than in group 3 (P = 0.001).
CONCLUSION: The conjunctival changes in PEX and PEXG patients recorded in this study may explain the existence of tear film abnormalities in these patients. It has been shown that PEXG and PEX syndrome cause conjunctival surface changes and reduction of tear film functions.

Entities:  

Mesh:

Year:  2006        PMID: 16626422     DOI: 10.1111/j.1442-9071.2006.01168.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  8 in total

1.  Conjunctival changes in different clinical variants of early pseudoexfoliation.

Authors:  Aparna Rao; Gopinath Das; Sarada Sarangi; Debananda Padhy
Journal:  Int Ophthalmol       Date:  2017-10-30       Impact factor: 2.031

Review 2.  [Diagnosis and therapy of pseudoexfoliation glaucoma].

Authors:  A G M Jünemann
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

3.  German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye.

Authors:  Carl Erb; Ulrike Gast; Dieter Schremmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-22       Impact factor: 3.117

4.  Transient expression of Wnt5a elicits ocular features of pseudoexfoliation syndrome in mice.

Authors:  Yong Yuan; Ursula Schlötzer-Schrehardt; Robert Ritch; Mindy Call; Fred B Chu; Fei Dong; Taylor Rice; Jianhua Zhang; Winston W-Y Kao
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

Review 5.  Changes in peri-ocular anatomy and physiology in pseudoexfoliation syndrome (Review).

Authors:  Efstathios T Detorakis; Georgios Bontzos; Eleni E Drakonaki; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2021-04-19       Impact factor: 2.447

6.  Ocular Surface Disease Signs and Symptoms in Patients with Pseudoexfoliative Glaucoma: A Case-Control Study.

Authors:  Maria Dermenoudi; Artemis Matsou; Christina Keskini; Eleftherios Anastasopoulos
Journal:  Vision (Basel)       Date:  2022-02-08

7.  Tear film abnormalities in pseudoexfoliation syndrome and normal healthy participants: A comparative analysis.

Authors:  Shukrullah Noori; Alok Sati; P S Moulick; Jaya Kaushik; Sandeep Shankar; Rupali Bose
Journal:  Med J Armed Forces India       Date:  2019-05-28

Review 8.  A Case-Cohort Study of Exfoliation Risk Factors and Literature Review.

Authors:  Ahmad M Mansour; Anastasios G P Konstas; Hana A Mansour; Abdul R Charbaji; Khalil M El Jawhari
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.